Skip to main content

The Toronto Blue Jays did not offer third baseman Josh Donaldson a contract extension prior to trading him to the Cleveland Indians last week, according to Donaldson’s agent.

A report from Jon Heyman of Fancred on Thursday said the Jays “extended an offer for more than the three-year, $75 million deal the Phillies gave to free agent pitcher Jake Arrieta, another major star older than 30. The belief is they were flexible to go at least a bit higher.

“... However, word is that after Donaldson initially seemed willing to continue talks, bringing brief hope for a deal, ultimately his camp suggested a figure range that put the sides far apart enough that talks discontinued.”

Story continues below advertisement

Donaldson’s agent, Dan Lozano of the MVP Sports Group, denied the report in an emailed statement to multiple media outlets.

“The fact is that the team never extended an offer to Josh, no years or dollars were ever specifically discussed, and it’s unfair to Josh for someone to repeatedly misrepresent his business affairs citing their ‘beliefs,’” Lozano said.

Lozano also referenced a previous report from Heyman about an extension in February that Donaldson had personally disputed on Twitter at the time.

Donaldson was dealt from the Blue Jays to the Indians on Aug. 31 for a player to be named.

The Indians subsequently placed Donaldson on the 10-day disabled list Monday as he continues to recover from a left calf strain that has sidelined him since May 28.

Donaldson, the 2015 American League MVP, played in just 36 games for the Blue Jays this season, hitting .234 with five home runs and 16 RBIs. He is making $23 million this year and becomes a free agent in the offseason.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter